TransMedics Group, Inc. (NASDAQ: TMDX) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT TRANSMEDICS GROUP, INC.

TransMedics Group, Inc. (NASDAQ: TMDX)
Listen to this Section


$68.58
+0.1300 ( +0.19% ) 467.3K

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Market Data


Open $68.58
Previous Close $68.45
Volume 467.3K
Market Cap $2.37B
Day Range $66.82 - $69.03
52 Week Range $60.11 - $156.00
Shares Outstanding 34.56M
Change % +0.19%
Net Change ▲ 0.1300
Insider Ownership N/A
Exchange NASDAQ
SectorIndustrials
IndustryELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
IPO Year2019
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: 8,400.00

Date Type Amount Purchased Purchaser
2025-08-08 Buy 8400.00 Hassanein Waleed H

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Oct 31, 2025
8-k 8K-related 12 Oct 29, 2025
10-q Quarterly Reports 71 Oct 29, 2025
8-k 8K-related 12 Oct 06, 2025
4 Insider transactions 1 Aug 08, 2025
4 Insider transactions 1 Aug 05, 2025
8-k 8K-related 12 Jul 30, 2025
10-q Quarterly Reports 71 Jul 30, 2025
4 Insider transactions 1 Jun 10, 2025

Latest News


× Before browsing our site, please accept our cookies policy